Biotech Firms' Research Chiefs Balance Demands Of Science And Competition

Top scientists from eight companies discuss what it takes to maintain a creative and productive laboratory environment Back in 1983, scientists at Calgene Inc. in Davis, Calif., began to tinker with genetically engineered corn. Their goal at the time - to improve the vegetable's carbohydrate storage as well as its resistance to pests - seemed to make pretty good sense from both the scientific and the business points of view. Just five years later, however - after spending $5 million - Calgene

Written bySusan L-J Dickinson

| 11 min read

Save for Later

Listen with Speechify

0:00

11:00

Top scientists from eight companies discuss what it takes to maintain a creative and productive laboratory environment

Back in 1983, scientists at Calgene Inc. in Davis, Calif., began to tinker with genetically engineered corn. Their goal at the time - to improve the vegetable's carbohydrate storage as well as its resistance to pests - seemed to make pretty good sense from both the scientific and the business points of view.

Just five years later, however - after spending $5 million - Calgene plant pathologist Robert Goodman made a tough call: He decided to abort the whole project.

"It wasn't an easy decision to make," says Goodman, who until this summer was Calgene's vice president for research and development. "It was a good commercial opportunity, but we were unable to bring the technology on line fast enough. There were other projects that were closer to market and more certain commercially."

Too ...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!

Join for free today

Already a member? Login Here